He-He Hu Selected Research

poricoic acid A

7/2020	Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.
1/2020	Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

He-He Hu Research Topics

Disease

7	Fibrosis (Cirrhosis) 02/2021 - 11/2018
3	Ureteral Obstruction 12/2020 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2021 - 01/2020
1	Dyslipidemias (Dyslipidemia) 02/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020

Drug/Important Bio-Agent (IBA)

2	Adenine FDA LinkGeneric 02/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2020
2	poricoic acid AIBA 07/2020 - 01/2020
1	EicosanoidsIBA 02/2021
1	Bile Acids and Salts (Bile Acids)IBA 02/2021
1	ElectrolytesIBA 02/2021
1	LipidsIBA 02/2021
1	Lipoproteins (Lipoprotein)IBA 02/2021
1	ergosta-4,6,8(14),22-tetraen-3-oneIBA 01/2021
1	TriterpenesIBA 12/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2020
1	AcidsIBA 12/2020
1	NF-kappa B (NF-kB)IBA 12/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	CateninsIBA 01/2020
1	Complex MixturesIBA 11/2018
1	Therapeutic UsesIBA 11/2018

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2020
1	Nephrectomy 07/2020